Iran produces anti-MS drug |

Interferon beta-1D, which will enter the market under the brand name “Zephron”, was unveiled Wednesday at a ceremony at Tehran University of Medical Sciences.
The Minister of Health, Dr. Wahid Dastjerdi and Assistant President of the Republic for Scientific and Technical Affairs Sultankhawah participated in the closing ceremony of the curtain on the drug Zephron anti-disease “MS” or MS.

MS is a disease of the brain and spinal cord (central nervous system), which affects the brain’s ability to control the body’s functions and is called rigid because the disease affects the brain tissue hardened and replaced by solid (ineffective) tissues, and symptoms may be mild or diffuse any multiple times Appear to reflections.